¿Una pastilla para curar el cerebro? Un grupo de científicos intenta probarlanews2025-09-06T09:02:12+00:00September 6th, 2025|The New York Times|
How Rick Perry Became a Fervent Advocate for the Psychedelic Ibogainenews2025-08-11T18:19:05+00:00August 11th, 2025|The New York Times|
How Drinking Alcohol Affects You in Older Agenews2025-07-03T09:00:47+00:00July 3rd, 2025|The New York Times|
FDA Approves Journavx Drug to Treat Pain Without Addiction Risknews2025-01-31T00:12:17+00:00January 31st, 2025|The New York Times|
El medicamento innovador para vencer la adicción: ¿Ozempic?news2024-11-06T10:40:06+00:00November 6th, 2024|The New York Times|
From AI to Musk’s Brain Chip, the F.D.A.’s Device Unit Faces Rapid Changenews2024-11-01T23:57:56+00:00November 1st, 2024|The New York Times|
What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trialsnews2024-10-23T14:19:56+00:00October 23rd, 2024|The New York Times|
Why We May Soon Use Ozempic to Treat Addictionnews2024-10-18T12:20:09+00:00October 18th, 2024|The New York Times|
FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’snews2024-07-02T18:58:44+00:00July 2nd, 2024|The New York Times|
